ClinIics in Liver Disease - August 2008
1 Savino Bruno, MD Milano, Italy This activity is supported by an independent medical education grant from AbbVie, Bristol-Myers Squibb and Gilead Sciences.
Sanaa Kamal, M.D., Ph.D. Professor Ain Shams University, Cairo, Egypt Clinical Challenges in the Management of Hepatitis C Genotype 4.
1 Stefan Zeuzem, MD Frankfurt, Germany This activity is supported by an independent medical education grant from AbbVie, Bristol-Myers Squibb and Gilead.
EASL 2011 31 March 2011 - Berlin, Germany Impact of IL28B Genotype and Pre-treatment Serum IP-10 in Treatment-Naïve Genotype 1 HCV Patients Treated with.
Best of HCV from EASL
